MY ACCOUNT | NEWSLETTER |

World Veterinary Association and Brooke launch world’s first Essential Veterinary Medicines List (EVML) for Food Producing Animals


The World Veterinary Association (WVA) and global animal welfare organisation Brooke have launched the first-ever global list of essential veterinary medicines for food producing animals. The list will help to improve access to safe and effective medicines and vaccines for veterinarians around the world and act as a valuable tool to help respond to the global threat of Antimicrobial Resistance (AMR) and to support pandemic prevention preparedness plans under development.

The list contains core medicines and vaccines, selected for their relevance, efficacy and cost effectiveness by expert working groups. The phase 1 of this important project provides the essential medicinal needs of equids, large ruminants, pigs, goats and sheep. Phase 2 has started and focuses on poultry, rabbits, while phase 3 will follow with the inclusion of aquaculture and bees.

‘The EVML will help veterinarians and authorities in making better choices of medicines, biologics and vaccines supply, fitting to local needs.  As veterinarians we are gatekeepers of the next pandemic because of the profound roles we play in the control of zoonoses, this is a responsibility that we share with authorities and agencies in our various jurisdictions. Together, we stamp our feet in the one-health pathway.’

Dr Olatunji Nasir, WVA’s Pharmaceutical Stewardship Working Group Chair

‘We are incredibly proud to have led the development of the EVML alongside the WVA. This list is the product of global veterinary expertise and collaboration and is a critical first step in ensuring all animals around the globe have access to medicines and vaccines to keep them healthy and minimise their pain and suffering.’

Dr Shereene Williams, Brooke’s Senior Manager of Global Animal Health

Animal health, which is deeply interconnected with human and environmental health, is dependent on access to safe and effective veterinary medicines. However, in many regions around the world, these are not readily available. The World Health Organization (WHO) estimates that around two billion people have no access to essential medicines and it is believed the issue is even worse within animal populations. In a survey of veterinarians conducted by the founders of the list, 80% of respondents felt that challenges in accessing veterinary medicines restricts veterinarians’ ability to address animal health and welfare.

WVA and Brooke’s EVML list gives regulatory authorities and governments a blueprint for countries or regions to develop their own tailored lists, considering the pathogens and diseases specific to their region. This will help ensure that medicines and therapeutics are more readily available to all veterinary professionals and help prevent future pandemics of zoonotic diseases like COVID-19 and avian influenza. The list is a valuable tool in reducing the growing threat of AMR and adheres to World Organisation for Animal Health (WOAH) recommendations on prudent antimicrobial use.

As with the WHO’s Model Lists of Essential Medicines, the EVML for food producing animals  will be a free-to-access resource regularly updated on a calendared basis, seeking global contributions to ensure its continued relevance and effectiveness.


Source: https://worldvet.org/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Zoetis is Redefining the Feline Veterinary Experience with the Commercial Launch of Bonqat® (pregabalin oral solution) in the U.S.

Like0
Dislike0

Spatio-temporal patterns of tick-borne disease diagnoses in Indiana, USA (2009–2018)

Like0
Dislike0

Abdominal ultrasonographic findings of cats with feline infectious peritonitis: an update

Like0
Dislike0

Pseudohyperkalemia in horses with rhabdomyolysis reported by an enzymatic chemistry analyzer

Like0
Dislike0

Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2024 - All Rights Reserved
ISSN 2768-198X

Top